Sign Up to like & get
recommendations!
0
Published in 2019 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofz360.745
Abstract: Abstract Background CREs have been described worldwide and these isolates are often multidrug resistant with few therapeutic options remaining active against them. New β-lactam (BL)/β-lactamase inhibitor (BLI) combinations recently approved are active against KPC and…
read more here.
Keywords:
cre isolates;
qpx;
lactamase inhibitor;
etp ... See more keywords